Supporting individuals and organisations

Cardiac Contractility Modulation in Dilated Cardiomyopathy: an exploratory study on the changes in myocardial metabolic profile

Exercise phenotypes to accelerate the personalized treatment of heart failure with preserved ejection fraction

ECSPAND: Exercise capacity improvement by Conduction System Pacing in heArt failure patieNts without compelling CRT inDication

Characterizing the spatiotemporal transcriptional landscape of neural crest cell lineages in a zebrafish model for Myhre syndrome

Deciphering Molecular Pathways of Hypoxia Sensitivity in Adult Cardiomyocytes: An Integrative Cross-Species Investigation

Unraveling the role of retinal imaging as a clinical tool in evaluating accelerated aging in congenital heart disease

Identification of cell-specific disease genes for bicuspid aortic valve-related aortopathy by transcriptome-wide spatial profiling of a representative Smad6 mutant mouse model

Assessment of polygenic background to explain the association between small heart size and low cardiac fitness (GEN@HEART)

The value of 7-day rhythm surveillance as a novel tool for risk prediction in acute myocarditis

The incidence of cardiovascular events and revascularizations in patients treated with Immune Checkpoint Inhibitors in Belgium.

Exploring the cell-specific mechanisms of aortic disease using fibrillin-1 mutant mouse models.

Role of adiponectin and PD-L1 in the release of cardioprotective exosomes

Renal-based optimization of Quadruple therapy in patients with Heart Failure with reduced ejection fraction (ReQUAD-HF): a prospective, multicentre, international randomised-controlled trial

Bestuderen moleculaire mechanismen rond eiwitacetylatie/diabetische cardiomyopathie / Étude des mécanismes moléculaires liés à l'acétylation des protéines/la cardiomyopathie diabétique

Myo-inositol/SMIT1 axis: a novel pathway to prevent of treat heart failure

Eccentric overload training in addition to a traditional cardiac rehabilitation programme: randomized controlled trial to evaluate effectiveness and feasibility in heart failure patients with reduced

Study of the cellular and molecular mechanisms underlying cardiomyopathy caused by transcription factor PR domain containing 16 (Prdm16) deficiency in cardiomyocytes and non-cardiomyocyte cell types

Preclinical and clinical assessment of the beneficial effects of hepcidin, a pivotal endogenous regulator of iron metabolism, on anthracycline-induced cardiotoxicity.

Conduction system pacing: a bench and bedside study. Insights in cardiac conduction disease translated to novel pacing strategies.

Prospective evaluation of cardiac remodeling in young competitive athletes – Identification of genetic and environmental determinants (PRO@HEART)

Supervised home-based combined endurance resistance exercise training programme in asymptomatic adult patients with congenital heart disease. A prospective randomised-controlled trial to evaluate effectiveness, safety and quality of life

Prevention of recurrence of hypertensive pregnancy disorders in women with active desire for pregnancy, a randomized controlled trial: a smartphone-based aerobic exercise training program during pregnancy versus usual care

Generation and characterization of three novel induced pluripotent stem cell-derived cardiomyocyte lines as a model to study the pathophysiological mechanisms of arrhythmogenic cardiomyopathy

Cardiovascular disease and cancer are linked through the NRG1/ERBB3 signaling system

SURGICAL-AF 2 study: The clinical impact of remote heart rhythm monitoring by photoplethysmography-based smartphone technology in the rehabilitation after cardiac surgery: A randomized, open-label, multicenter, pragmatic clinical trial

Contribution of BMP-SMAD regulated biogenesis of microRNAs in organ-specific functions of lymphatic endothelium

Importance of protein O-GlcNAcylation in cardiac hypertrophy development

Limiting platelet lipid synthesis: a defense mechanism against atherothrombosis in coronary artery disease ?

Discovering the role of titin (TTN) in anthracycline-induced cardiac dysfunction in breast cancer.